Elevated activity of transcription factor nuclear factor of activated T-cells 5 (NFAT5) and diabetic nephropathy

Diabetes

Volumn 55, Issue 5, 2006, Pages 1450-1455

  Yang, Bingmei ^a   Hodgkinson, Andrea D ^a   Oates, Peter J ^b   Hyug, Moo Kwon ^c   Millward, Beverley A ^a   Demaine, Andrew G ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

HMC, human mesangial cell; NFAT5, nuclear factor of activated T cells 5; ORE, osmotic response element; PBMC, peripheral blood mononuclear cell; SDH, sorbitol dehydrogenase; TonEBP, tonicity response element binding protein

Indexed keywords

ALDEHYDE REDUCTASE; CYTOPLASM PROTEIN; GLUCOSE; IDITOL DEHYDROGENASE; MESSENGER RNA; NUCLEAR PROTEIN; POLYOL; TRANSCRIPTION FACTOR NFAT; NFAT5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA BINDING; DNA RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; KIDNEY CARCINOMA; MESANGIUM CELL; MICROANGIOPATHY; NEPHRECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; OSMOSIS; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; RISK FACTOR; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING; ADULT; AGED; CAUCASIAN; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MESANGIUM; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ADULT; AGED; ALDEHYDE REDUCTASE; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLOMERULAR MESANGIUM; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REFERENCE VALUES; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 33745295937     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db05-1260     Document Type: Article

References (39)

1. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
2. Hansen SH: The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17:330-346, 2001
3. Dunlop M: Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77:S3-S12, 2000
4. Smardo FL Jr, Burg MB, Garcia-Perez A: Kidney aldose reductase gene transcription is osmotically regulated. Am J Physiol 31:C776-C782, 1992
5. Ko BCB, Ruepp B, Bohren KM, Gabbay KH, Chung SSM: Identification and characterisation of multiple osmotic response sequences in the human aldose reductase gene. J Biol Chem 272:16431-16437, 1997
6. Aida K, Tawata M, Ikegishi Y, Onaya T: Induction of rat aldose reductase gene transcription is mediated through the cis-element, osmotic response element (ORE): increased synthesis and/or activation by phosphorylation of ORE-binding protein is a key step. Endocrinology 140:609-617, 1999
7. Miyakawa H, Woo SK, Chen CP, Dahl SC, Handler JS, Kwon HM: Cis-and trans-acting factors regulating transcription of the BGT1 gene in response to hypertonicity. Am J Physiol 274:F753-F761, 1998
8. Rim JS, Atta MG, Dahl SC, Verry GT, Handler JS, Kwon HW: Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonocity-responsive enhancers spread over 50 kilobase pairs in the 5′flanking region. J Biol Chem 273:20615-20621, 1998
9. Miyakawa H, Woo SK, Dahl SC, Handler JS, Kwon HM: Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity. Pro Nat Acad Sci USA 96:2538-2542, 1999
10. López-Rodríguez C, Aramburu J, Rakeman A, Rao A: NFAT5, a constitutively nuclear NFAT protein that dose not cooperate with Fos and Jun. Pro Nat Acad Sci USA 96:7214-7219, 1999
11. Shimizu H, Ohtani KI, Tsuchiya T, Sato N, Tanaka Y, Takahashi H, Uehara Y, Inukai T, Mori M: Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese type 2 diabetic (T2DM) patients. Diabetes Nutr Metab 13:75-79, 2000
12. Hasegawa G, Obayashi H, Kitamura A, Hashimoto M, Shigeta H, Nakamura N, Kondo M, Nishimura CY: Increased levels of aldose reductase in peripheral mononuclear cells from type 2 diabetic patients with microangiopathy. Diabetes Res Clin Pract 45:9-14, 1999
13. Shah VO, Dorin RI, Sun Y, Braun M, Zager PG: Aldose reductase gene expression is increased in diabetic nephropathy. J Clin Endocrinol Metab 82:2294-2298, 1997
14. Hodgkinson AD, Sóndergaard KL, Yang B, Cross DF, Millward BA, Demaine AG: Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy. Kidney Int 60:211-218, 2001
15. Hamada Y, Kitoh R, Raskin P: Increased activity of erythrocyte aldose reductase in insulin-dependent diabetes with severe diabetic complications (Abstract). Diabetes 40 (Suppl. 1):9A, 1991
16. Maeda S, Haneda M, Yasuda H, Tachikawa T, Isshiki K, Koya D, Terada M, Hidaka H, Kashiwagi A, Kikkawa R: Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes. Diabetes 48:420-422, 1999
17. Kasajima H, Yamagish SI, Sugai S, Yagihashi N, Yagihash Y: Enhanced in situ expression of aldose reductase in peripheral nerve and renal glomeruli in diabetic patients. Virchows Arch 439:46-54, 2001
18. Moriyama T, Garcia-Perez A, Burg MB: Osmotic regulation of aldose reductase protein synthesis in renal medullary cells. J Biol Chem 264:16810-16814, 1989
19. Trama J, Lu Q, Hawley RG, Ho SN: The NFAT-related protein NFATL1 (NFAT5/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner. J Immunol 165:4884-4894, 2000
20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 (Suppl. 1):S5-S20, 2003
21. Heesom AE, Hibberd ML, Millward BA, Demaine AG: A polymorphism at 5′ end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type 1 daibetes. Diabetes 46:287-291, 1997
22. Mené P: Mesangial cell cultures. J Nephrol 14:198-203, 2000
23. Na KY, Woo SK, Lee SD, Kwon HM: Silencing of TonEBP/NFAT5 transcriptional activator by RNA interference. J Am Soc Nephrol 14:283-288, 2003
24. Yang B, Millward A, Demaine A: Functional differences between the susceptibility Z-2/C-106 and protective Z+2/T-106 promoter region polymorphisms of the aldose reductase gene may account for the association with diabetic microvascular complications. Biochim Biophys Acta 1639:1-7, 2003
25. Ferraris JD, Williams CK, Jung KY, Bedford JJ, Burg MB, García-Pérez A: ORE, a eukaryotic minimal essential osmotic response element: the aldose reductase gene in hyperosmotic stress. J Biol Chem 271:18318-18321, 1996
26. Ferraris JD, Williams CK, Ohtaka A, Garcia-Perez A: Functional consensus for mammalian osmotic response elements. Am J Physiol 276:C667-C673, 1999
27. Woo SK, Dahl SC, Handler JS, Kwon HM: Bidirectional regulation of tonicity-responsive enhancer binding protein in response to changes in tonicity. Am J Physiol Renal Physiol 278:F1006-F1012, 2000
28. Dalski A, Schwinger E, Zühlke C: Genomic organisation of the human NFAT5 gene: exon-intron structure of the 14-kb transcript and CpG-island analysis of the promoter region. Cytogenet Cell Genet 93:239-241, 2001
29. Yang B, Hodgkinson A, Millward A, Demaine A: Abnormal differetial expression of two isforms of tonicity response element binding protein in patients with type 1 diabetes and nephropathy (Abstract). Diabetes 50 (Suppl. 2):A183, 2001
30. Maouyo D, Kim JY, Lee SD, Wu Y, Woo SK, Kwon HM: Mouse TonEBP-NFAT5: expression in early development and alternative splicing. Am J Physiol Renal Physiol 282:F802-F809, 2002
31. Dalski A, Wagner HJ, Schwinger E, Zühlke C: Quantitative PCR analysis of different splice forms of NFAT5 revealed specific gene expression in fetal and adult brain. Mol Brain Res 83:125-127, 2000
32. Hodgkinson AD, Page T, Millward BA, Demaine AG: A novel polymorphism in the 5′ flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with type 1 diabetes mellitus. J Diabetes Complications 19:65-69, 2005
33. Ibrahim NH, Hostetter TH: Diabetic nephropathy. J Am Soc Nephrol 8:487-493, 1997
34. Nadkarni V, Gabbay KH, Bohren KM, Sheikh-Hamad D: Osmotic response element enhancer activity: regulation through p38 kinase and miltogen-activated extracellulr signal-regulated kinase kinase. J Biol Chem 274:20185-20190, 1999
35. Ko BCB, Lam AKM, Kapus A, Fan L, Chung SK, Chung SSM: Fyn and p38 signaling are both required for maximal hypertonic activation of the OREBP/TonEBP. J Biol Chem 277:46085-46092, 2002
36. Nahm O, Woo SK, Handler JS, Kwon HM: Involvement of multiple kinase pathways in stimulation of gene transcription by hypertonicity. Am J Physio Cell Physiol 282:C49-C58, 2002
37. Fazzio A, Spycher SE, Azzi A: Signal transduction in rat vascular smooth muscule cells: control of osmotically induced aldose reductase expression by cell kinases and phosphatases. Biochem Biophys Res Commu 255:12-16, 1999
38. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig KO, Zhu M, Concepcion LA, Brosius IIII FC: Dglucose stimulates mesangial cell GLUT1 expression and basal and IGF-1-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy. Diabetes 46:1030-1039, 1997
39. Liu ZH, Chen ZH, Li YJ, Liu D, Li LS: Phenotypic alterations of live mesangial cells in patients with diabetic nephropathy obtained from renal biopsy specimen (Abstract). J Am Soc Nephrol 10:A0669, 1999